HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.

Abstract
Valproic acid(VPA) is a classic drug that used to treat epilepsy in monotherapy or combination with other anticonvulsant drugs such as lamotrigine (LTG). Although it was reported that VPA could increase lamotrigine trough concentration in clinical practice, there was no report about the effect of LTG on the trough concentration of VPA and its main metabolites, such as 4-ene-VPA, 3-OH-VPA, 4-OH-VPA, 3-keto-VPA, 2-PGA which are related to the therapeutic and toxic effects of VPA. In this study, a simple and rapid method for the simultaneous determination of VPA and its five metabolites in human plasma using HPLC-MS/MS was developed for the first time. Benzoic acid was used as an internal standard (IS). Separation was performed on a Hypersil GOLD C18 column by isocratic elution using acetonitrile: 10mM ammonium acetate solution (90:10, v/v) as mobile phase at a flow rate of 0.3mL/min. A triple quadrupole mass spectrometer operating in the negative ion-switching, electron spray ionization mode with selection reaction monitoring (SRM) was employed to determine transitions of m/z 143.183→143.183, 157.033→113.165, 173.017→129.074, 159.058→101.082, 140.870→140. 870, 159.049→123.076, 121.035→77.136 for VPA, 2-PGA, 3-keto-VPA, 3-OH-VPA, 4-ene-VPA, 4-OH-VPA and IS, respectively. The method also afforded satisfactory results in terms of sensitivity, specificity, precision (intra- and inter-batch), accuracy, recovery, matrix effect and stability. This method was successfully applied to evaluate the effect of LTG on the trough concentration of VPA, 2-PGA, 3-keto-VPA, 3-OH-VPA, 4-ene-VPA, 4-OH-VPA in Chinese epilepsy patients. The result showed that there was no significant difference in the concentration of VPA and its five metabolites between patients in VPA monotherapy and patients in therapy combining VPA with LTG.
AuthorsDingsheng Wen, Ziyi Chen, Chao Yang, Huanbin Liu, Hongliang Li, Juan Chen, Qiling Dai, Guoping Zhong, Jiaming Qin, Guanzhong Ni, Min Huang, Liemin Zhou, Xueding Wang
JournalJournal of pharmaceutical and biomedical analysis (J Pharm Biomed Anal) Vol. 149 Pg. 448-456 (Feb 05 2018) ISSN: 1873-264X [Electronic] England
PMID29169113 (Publication Type: Journal Article, Validation Study)
CopyrightCopyright © 2017 Elsevier B.V. All rights reserved.
Chemical References
  • Anticonvulsants
  • Triazines
  • Valproic Acid
  • Lamotrigine
Topics
  • Adolescent
  • Adult
  • Anticonvulsants (blood, pharmacokinetics, therapeutic use)
  • Asian People
  • Chromatography, High Pressure Liquid (instrumentation, methods)
  • Drug Interactions
  • Drug Therapy, Combination (methods)
  • Epilepsy (blood, drug therapy)
  • Female
  • Humans
  • Lamotrigine
  • Male
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry (instrumentation, methods)
  • Time Factors
  • Triazines (blood, pharmacokinetics, therapeutic use)
  • Valproic Acid (blood, pharmacokinetics, therapeutic use)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: